Spencer B. King

Active 1976–2022

Also published as
Spencer B King
137
Papers
41,476
Citations
104
h-index
137
i10-index

Citations

Citations per year for Spencer B. King1979: 4 citations1980: 1 citations1981: 7 citations1982: 2 citations1983: 5 citations1984: 12 citations1985: 22 citations1986: 18 citations1987: 38 citations1988: 109 citations1989: 73 citations1990: 137 citations1991: 136 citations1992: 135 citations1993: 160 citations1994: 187 citations1995: 222 citations1996: 226 citations1997: 211 citations1998: 216 citations1999: 203 citations2000: 205 citations2001: 214 citations2002: 147 citations2003: 146 citations2004: 130 citations2005: 172 citations2006: 128 citations2007: 223 citations2008: 181 citations2009: 255 citations2010: 280 citations2011: 321 citations2012: 238 citations2013: 284 citations2014: 233 citations2015: 151 citations2016: 140 citations2017: 147 citations2018: 113 citations2019: 372 citations2020: 346 citations2021: 282 citations2022: 174 citations2023: 127 citations2024: 182 citations2025: 62 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,637 citing papers, 31.2% of this breakdownUnited Kingdom: 619 citing papers, 7.3% of this breakdownGermany: 478 citing papers, 5.7% of this breakdownItaly: 462 citing papers, 5.5% of this breakdownNetherlands: 462 citing papers, 5.5% of this breakdownCanada: 441 citing papers, 5.2% of this breakdownFrance: 289 citing papers, 3.4% of this breakdownChina: 279 citing papers, 3.3% of this breakdownJapan: 249 citing papers, 2.9% of this breakdownAustralia: 207 citing papers, 2.5% of this breakdownSwitzerland: 188 citing papers, 2.2% of this breakdownSpain: 173 citing papers, 2% of this breakdown
0%31.2%Other 23.3%

Fields

  • Medicine89.1%
  • Biochemistry, Genetics and Molecular Biology3.8%
  • Engineering2.3%
  • Immunology and Microbiology0.9%
  • Health Professions0.8%
  • Economics, Econometrics and Finance0.6%
  • Other2.5%

Topics

  • Coronary Interventions and Diagnostics16.8%
  • Cardiac Imaging and Diagnostics11.4%
  • Acute Myocardial Infarction Research9.5%
  • Antiplatelet Therapy and Cardiovascular Diseases4.2%
  • Cardiac and Coronary Surgery Techniques3.8%
  • Peripheral Artery Disease Management2.1%
  • Other52.2%

Coauthors

All papers

Open in search
  1. Strategies for Multivessel Revascularization in Patients with Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,902

  2. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 1,559

  3. High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 176

  4. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 2,417

  5. Cardiac Shock Care Centers

    Authors: , , , , , , , - Journal of the American College of Cardiology 2018 cited by 172

  6. Combination of plaque burden, wall shear stress, and plaque phenotype has incremental value for prediction of coronary atherosclerotic plaque progression and vulnerability

    Authors: , , , , , , , , , , , - Atherosclerosis 2013 cited by 131

  7. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

    Authors: , , , , , , , , , - Circulation 1988 cited by 2,128

  8. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2002 cited by 260

  9. Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices

    Authors: , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2000 cited by 112

  10. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).

    Authors: , , , , , , , - Circulation 1993 cited by 400

  11. Percutaneous Coronary Intervention Versus Coronary Bypass Surgery in United States Veterans With Diabetes

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 160

  12. Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization

    Authors: , , , , , , , , , - Circulation Cardiovascular Interventions 2022 cited by 69

  13. Percutaneous Coronary Revascularization

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 43

  14. Integration of Pre-Hospital Electrocardiograms and ST-Elevation Myocardial Infarction Receiving Center (SRC) Networks

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2009 cited by 191

  15. The New York State Cardiac Registries

    Authors: , , , , - Journal of the American College of Cardiology 2012 cited by 164

  16. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

    Authors: , , - Circulation 1989 cited by 929

  17. Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2007 cited by 802

  18. Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2000 cited by 317

  19. A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2006 cited by 205

  20. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard L. Page, Bárbara Riegel, Lynn G. Tarkington, Clyde W. Yancy - Circulation 2007 cited by 1,020

  21. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

    Authors: , , , , , , - Circulation 1988 cited by 658

  22. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

    Authors: , , , , , - Journal of the American College of Cardiology 2008 cited by 611

  23. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty.

    Authors: , , , , , - Circulation 1985 cited by 431

  24. Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 358